MoneyWorks4Me

Glenmark Life Sciences informs about disclosure

26 Sep 2023 Evaluate
Glenmark Life Sciences has informed that it enclosed the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nirma.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1842.10
Dr. Reddys Labs. 1225.00
Cipla 1389.85
Lupin 2069.50
Zydus Lifesciences 1216.50
View more..